Researchers have identified key genetic changes required for the H5N1 avian influenza virus to adapt to easily recognize human receptors. The study provides a molecular blueprint for these changes, which could help detect pandemic strains earlier and prepare public health officials and vaccine manufacturers.
Researchers at FSU's Magnet Lab, in partnership with Brigham Young University, are studying the Influenza Type A virus using advanced NMR technology. They have discovered key components of protein channels that regulate viral gene distribution and reproduction.
Researchers found that some viruses, like the human polyomavirus JCV, may be evolving at higher rates than previously assumed. The virus is traditionally used as a genetic marker for human migration and evolution, but its reliability has been called into question by this new study.
A team of NIAID scientists identified a human protein that helps varicella-zoster virus spread from cell to cell. Interfering with this interaction inhibits the virus' spread, and blocking it may lead to new therapies for shingles.
Scientists have developed a vaccine that protects mice against the 1918 influenza virus, which killed 50 million people worldwide. The vaccine works by stimulating antibodies capable of neutralizing the virus, providing a potential solution to future pandemic flu strains.
A comprehensive mouse study provides new clues about the virulence of the 1918 influenza virus. The research found that a hyperactive immune response triggered by the virus may contribute to its exceptional lethality. Understanding this phenomenon is crucial for developing therapies against future flu pandemics.
A study found that herpes virus infects cornea cells through a process similar to how phagocytes engulf foreign invaders, allowing the virus to evade the immune system. This unusual pathway opens up new strategies for developing therapies against ocular herpes and has implications for understanding other herpes virus infections.
Scientists at the University of Texas Medical Branch at Galveston have determined the precise structure of the VEE virus protein required for replication. This achievement marks an important step toward developing effective drug therapies against the virus, which can cause widespread infections and death in Central and South America.
Researchers at Ohio State University have discovered how a chemotherapy drug aids an anti-cancer virus in targeting brain tumors. The study found that the drug slows immune cells' activity, allowing the virus to spread and kill more cancer cells. This may lead to new treatment options for incurable human brain tumors.
The University of Pittsburgh School of Medicine has received a $1.3 million grant to produce a promising avian flu vaccine that could protect against the deadly H5N1 virus. The vaccine, developed by Dr. Andrea Gambotto's team, has shown complete protection in mice and chickens against infection.
Researchers at University at Buffalo found that methamphetamine increases expression of DC-SIGN receptor, allowing more virus to invade the immune system and promote HIV infection. The study suggests that dopamine receptor blockers could be beneficial in reducing HIV infection in high-risk populations.
Researchers at the Mayo Clinic have engineered a modified measles virus that specifically targets and kills cancer cells by recognizing unique protein secretions. This breakthrough enhances the safety and effectiveness of oncolytic virotherapy, reducing the risk of unintended infections while improving cancer treatment outcomes.
A novel mechanism of dengue virus replication has been discovered, involving the circularization of its genome. This process allows the viral RNA polymerase to interact with a distant site on the genome, initiating replication. The study's findings suggest a widespread strategy for viral RNA replication.
Researchers at MSU have developed a new cell line that can grow nearly all types of flu viruses, potentially leading to faster and cheaper vaccine production. This could help address the issues with traditional influenza vaccine production methods, including long production times and limited supply.
Researchers studied gorilla population during Ebola outbreak and found transmission between groups led to high mortality rate. The study suggests ape-to-ape transmission plays a significant role in the spread of the virus.
The study revealed the outer lipid envelope interacts with the capsid shell of hepatitis B virus, which is enormous and nearly 10 times larger than a hemoglobin molecule. The findings may offer new clues on how the virus replicates in vivo.
Researchers found that mice lacking MHC Class I molecules can still mount an effective CD8 T cell response against chronic herpes virus infections. This suggests the presence of a backup immune system component that can recognize and fight viral proteins without relying on MHC Class I.
The Chikungunya outbreak in the Indian Ocean affects several islands and India, with a large portion of populations infected. The disease is caused by the chikungunya virus, spread by mosquito bites, and has no specific treatment. Genetic analysis reveals unique molecular features among outbreak strains.
Researchers develop a modified virus that targets telomerase-positive cancer cells, inducing autophagy to kill them. The treatment reduces tumor size and extends survival in mice with malignant glioma. Autophagy is a protective process that cells use to consume part of themselves when nutrients are scarce.
Researchers used mathematical modeling to simulate worldwide outbreaks and concluded that restrictions on air travel would achieve very little in controlling the spread of a new flu virus. Local measures such as vaccines and antiviral drugs could be more effective in controlling the spread of the virus.
Researchers have developed a vaccine that prevents haemorrhagic fever developing in monkeys infected with the deadly Marburg virus. The vaccine was found to be highly effective as a post-exposure treatment, with all treated monkeys surviving for at least 80 days.
A new experimental vaccine has been shown to protect nonhuman primates against Marburg virus infection, even when administered after exposure. The study found that all treated monkeys survived for at least 80 days, while controls succumbed to the disease within 12 days.
Researchers have developed a new hybrid virus that can target tumors systemically to deliver an imaging or therapeutic gene, allowing for the monitoring of drug effectiveness at the molecular level. This breakthrough could lead to improved diagnosis, monitoring, and treatment of human cancers.
Researchers discovered a novel biological process that allows poxviruses to enter cells by disrupting their outer membrane. Polyionic compounds can be used to treat poxvirus infections, even days after infection has started, making antiviral antibodies more effective.
Stanford scientist Sarnow discusses new approach to treating hepatitis C virus using microRNA, a small fragment of RNA found in the liver that is necessary for viral growth and reproduction. The approach aims to lower microRNA levels in the liver without affecting liver function, potentially leading to improved treatment outcomes.
A new approach to controlling swine disease, known as acclimatization, was tested on a farm in Illinois. The study found that pigs exposed to the farm's wild-type virus developed immunity but suffered reproductive issues, casting doubt on its effectiveness.
Researchers at Ohio State University have discovered that a cancer virus protein is necessary for the virus to successfully infect and reproduce in the body. The protein, p13, plays a critical role in the early phase of infection, and its function could be targeted by new drugs or vaccines.
The study found that small mutations can change the binding site preference of the avian virus from bird to human receptors, increasing its chances of infection. This critical step is a key reason why most avian influenza viruses are not easily transmitted between humans.
Researchers found that Culex mosquitoes changed their feeding behavior from American robins to humans in the fall, leading to large-scale outbreaks of disease. The study's findings suggest a continent-wide phenomenon and may explain why West Nile virus outbreaks are more intense in the US than in Europe and Africa.
Researchers detected a novel virus, XMRV, in human prostate tumors with two copies of the RNASEL gene mutation. The study validates the use of DNA-hunting 'virus chip' technology to discover previously unknown viruses and potentially uncover new viral causes for disease.
Researchers at Purdue University have visualized the binding of the dengue virus to a key host cell receptor, DC-SIGN. The study provides new insights into how the virus initiates infection and could potentially lead to the development of new treatments.
Researchers genetically engineered an adenovirus to produce a protein from the H5N1 influenza virus, protecting mice from death and weight loss when infected with the virus. The human adenovirus vaccine generated specific T cells that helped clear the virus, offering a viable option for potential pandemic vaccination.
A vaccine developed by University of Pittsburgh Medical Center researchers has shown 100% protection against the avian flu virus in an animal study. The vaccine, which contains a live virus, stimulates several lines of immunity and is expected to have greater therapeutic value than traditional vaccines.
Researchers have developed hybrid antibodies from chimpanzees and humans that effectively inhibited the spread of vaccinia and variola viruses in test tube experiments. In mice infected with vaccinia virus, the hybrid antibodies proved more effective than anti-vaccinia immune globulin when given two days after virus exposure.
A study on H5N1 influenza virus infection in cats reveals systemic disease with widespread viral spread to various organ systems, including respiratory and digestive tracts. This finding has significant implications for understanding the mechanisms of avian influenza transmission to humans.
Researchers used novel antisense drugs to interrupt normal Ebola virus replication, showing protection in non-human primates. The therapy directly targets the virus and may be more potent than current anti-viral treatments.
Researchers found that group B coxsackieviruses infect cells through an indirect route, utilizing signaling pathways and exploiting more accessible receptors. This understanding may lead to future therapies to block viral infections and contribute to clinical benefits.
The study found that non-nucleoside reverse transcriptase inhibitor (NNRTI)-resistant viruses have an advantage over sensitive viruses even at low levels of adherence. NNRTI and protease inhibitors are potent antiretroviral drugs with demonstrated effectiveness when taken as directed.
Researchers at Thomas Jefferson University have identified a molecular mechanism involved in making the rabies virus pathogenic and lethal. They have developed a very safe vaccine for the immunization of wildlife, showing efficacy in raccoon, skunk, and mongoose species, offering new hope for prevention of deadly disease.
A team of researchers from the University of Wisconsin-Madison and the University of Tokyo report a new way to generate genetically altered influenza virus. This technique improves upon a previous reverse genetics method by significantly reducing the number of plasmid vectors required, increasing the efficiency of virus production.
Researchers analyzed genetic data and outbreak patterns to find that the Zaire strain of Ebola virus is spreading as a wave from its first epidemic in Yambuku, Gabon. This suggests that the virus may reach populated areas within 1-2 years and devastated gorilla populations in 3-6 years.
Researchers reconstructed the 1918 flu virus using reverse genetics, a technique developed by Mount Sinai School of Medicine researchers. The study reveals that the virus is extremely virulent in mice and grows rapidly in human lung cells.
A team of researchers has identified key genes responsible for the Spanish flu's extreme virulence, which could lead to the development of effective antivirals and vaccines. The study also suggests that certain FDA-approved flu medications may be effective against future strains of the virus.
A new study has tracked the evolution of the H3N2 influenza virus in New York over five flu seasons, revealing at least three distinct subpopulations of the virus. The research demonstrates the potential for genomics to inform vaccine development and improve public health by understanding the dynamics of flu virus evolution.
Researchers have discovered a novel mechanism used by tick-borne flaviviruses to counteract the natural ability of interferon to combat the virus. The study found that NS5 protein blocks immune defenses, preventing the immune system from stopping the spread of the virus and helping the body recover from infection.
Researchers found that the antibody prevents the virus from rearranging its protein envelope after entering host cells, blocking infection. The study also uncovered a theory called antibody-dependent enhancement, which may help explain why some antibodies are ineffective against certain viruses.
A new strain of equine influenza virus, H3N8, has been found to infect dogs in the US, with close to 100% of infected dogs showing symptoms. The virus is highly contagious and can spread rapidly throughout dog populations, making it a major concern for dog owners.
Researchers at Columbia University Irving Medical Center have developed a new type of virus, called a
A study found that HIV-infected macrophages travel to the temporal lobe, causing inflammation and damaging memories. Researchers hope to develop drugs targeting these cells to prevent HIV-associated dementia.
Researchers have developed a way to engineer an alternative outer covering for the measles virus, allowing it to recognize and target only cancerous cells. The 'virus in stealth' approach uses pieces from an animal virus that cannot infect humans to disguise the measles virus, enabling it to evade the immune system and reach tumors.
Researchers tested oseltamivir on mice infected with H5N1 virus, finding that higher doses for longer periods improved survival rates. The study suggests that antiviral drugs like oseltamivir may be effective in preventing and treating avian flu.
Researchers at Purdue University have determined the combined structure of Coxsackievirus A21 and ICAM-1, a receptor molecule that enables the virus to infect host cells. The study reveals how the virus recognizes and anchors to the cell, providing insights into the initial stages of infection.
Researchers identified a cell receptor called Ephrin-B2 as the key used by the Nipah virus to unlock cells, allowing them to develop vaccines and drugs to block viral entry. The discovery could help prevent infection and outbreaks of this deadly virus.
A new experimental vaccine has shown promising results in protecting nonhuman primates from Lassa fever. The vaccine, developed using a non-pathogenic form of vesicular stomatitis virus as a carrier, has been successfully tested with all vaccinated monkeys surviving infection.
A new study at the University of Wisconsin-Madison has streamlined a method for making large quantities of human papillomavirus, a major human pathogen. The technique allows scientists to culture any of the virus's 100 subtypes and genetically manipulate it, enabling faster development of therapeutic drugs and new vaccines.
A team of researchers has identified an intermediate stage in virus-cell fusion that lasts several minutes, providing a potential window of opportunity for drug development. This discovery may allow existing drugs to be re-evaluated and fine-tuned to target this critical point in the viral entry process.
Khalili will investigate the molecular mechanisms causing JC virus reactivation in AIDS patients, which can lead to the fatal disease PML. The researcher aims to understand how HIV triggers JC virus infections and develop new treatments for demyelinating diseases like MS.
Researchers found that between 2-6% of recipient mosquitoes acquired the virus in experiments, with a single bite from an infected donor mosquito infecting two out of 87 recipient mosquitoes. This new transmission method could accelerate disease spread by bypassing the need for high viremia levels.
A phase I study has shown early promise for a cancer-killing virus targeting colorectal cancer. The virus, NV1020, selectively kills cancer cells while sparing normal tissue, leading to improved CEA reductions and median survival times of up to 23 months.
Researchers have developed an infection-fighting antibody that successfully cures disease in mice infected with West Nile virus, even when the virus had entered their brains. The monoclonal antibody was several hundred times more potent than natural antibodies and completely protected mice against death.